BSECompany Update4 Aug 2026 · 4 Aug 2026, 06:28 pm
We hereby submit the Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding Appointment of Investor and Public Relations agency of the Company.
Speciality Medicines Ltd · 544738
✦ AI Summary
Speciality Medicines Ltd has appointed Capital Bridge Advisory Service Private Limited as its Investor and Public Relations Agency, enhancing its investor relations and capital market communication efforts.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Speciality Medicines Ltd - 544738 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Appointment Of Investor And Public Relations Agency Of The Company
Attachments (1)
📄pdf
Download →
a21e10c4-7f42-4915-ab96-fdc0b65f0150.pdf
View document text
Exporter & Trader of
Speciality Medicines
Date: - August 04, 2026
BSE Limited.
PJ Towers,
Dalal Street,
Mumbai – 400001
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 regarding Appointment of Investor and Public Relations Agency of the Company
Reference: Speciality Medicines Limited (Id: SPML; Code: 544738)
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish
to inform you that the company has appointed “Capital Bridge Advisory Service Private Limited” (operating under
the brand name Capital Bridge Advisors), having its registered office at 301, Vastubh Apartments, Dattapada Cross
Road No 1, Near Hanuman Temple, Borivali East, Mumbai - 400066, as our “Investor and Public Relations Agency"
for providing Investor and Public Relations Advisory Services.
Capital Bridge Advisory Service Private Limited will assist the company in enhancing its investor relations and
capital market communication efforts, with a focus on fostering meaningful engagement with the investment
community. This engagement reflects the company's continued commitment to strengthening its investor relations
framework, promoting greater transparency, and ensuring effective communication with stakeholders in line with the
evolving expectations of institutional and retail investors.
Details of the Investor and Public Relations Agency is as follows:
Research Team
Email: info@capbridge.in
Contact No.: +079 4918 4116
Corporate Office Address: 812 - 8th Floor,
Tower B, Shilp Corporate Park, Rajpath
Rangoli Road – 380058
This is for your information and records.
Yours Faithfully,
For, SPECIALITY MEDICINES LIMITED
(Formerly Known as Speciality Medicines Private Limited)
Parthkumar Goyani
Chairman and Managing Director
DIN: 07885789
Place: Mumbai
SPECIALITY MEDICINES LIMITED
(Formerly Known as Speciality Medicines Private Limited)
CIN: L85300GJ2021PLC120022
Corp. Office : Unit 27, Ground Floor, Andheri Sainath Premises Co Soc, 20 Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra, India, 400093
Regd. Office : 913, One World West, S. No. 396, FP 119, Village- Vejalpur, Ahmedabad 380051, Gujarat, India
+91 99242 03751 / 99242 43751 info@specialitymedicine.com www.specialitymedicine.com